undamentalytics Newsletter
Sign in

Invivyd, Inc. balance sheet

At the end of fiscal 2025, Invivyd, Inc. had total assets of $277m, total liabilities of $35.3m and shareholders' equity of $242m. It held $227m in cash against $0 of debt: net cash of $227m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents20169227160
Receivables0111411
Inventory026——
Total current assets225101247182
Total assets229130277219
Accounts payable810149
Total current liabilities50623431
Total debt0000
Total liabilities52623538
Shareholders' equity17768242181
Net debt (negative = net cash)−201−69−227−160
Shares outstanding110m120m—295m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: FENC vs IVVDIVVD vs NTLAIVVD vs NKTR

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Invivyd, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Invivyd, Inc.